BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,758 | -20.5% | 35 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,212 | +40.4% | 35 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,575 | -29.5% | 35 | -31.4% | 0.00% | 0.0% |
| Q4 2022 | $2,234 | -25.5% | 51 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | 0.0% | 51 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | -40.0% | 51 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $5,000 | -28.6% | 51 | -29.2% | 0.00% | -25.0% |
| Q3 2021 | $7,000 | +16.7% | 72 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $6,000 | -14.3% | 72 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $7,000 | +16.7% | 72 | +30.9% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | +50.0% | 55 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -42.9% | 55 | -42.7% | 0.00% | -20.0% |
| Q3 2019 | $7,000 | -30.0% | 96 | -8.6% | 0.01% | -28.6% |
| Q2 2019 | $10,000 | +25.0% | 105 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $8,000 | -11.1% | 105 | -5.4% | 0.01% | +50.0% |
| Q3 2018 | $9,000 | – | 111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |